| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/21/2001 | CA2394466A1 Polypeptides and nucleic acids encoding same |
| 06/21/2001 | CA2394213A1 Polypeptide compositions with improved stability |
| 06/21/2001 | CA2394160A1 Human oxidoreductase proteins |
| 06/21/2001 | CA2394130A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds |
| 06/21/2001 | CA2393972A1 Cyclopenteneone derivatives |
| 06/21/2001 | CA2393762A1 Hydroxide-releasing agents as skin permeation enhancers |
| 06/21/2001 | CA2393672A1 Selective neurokinin antagonists |
| 06/21/2001 | CA2393255A1 Nutritional composition, methods of producing said composition and methods of using said composition |
| 06/21/2001 | CA2392992A1 Imidazopyrimidinyl and imidazopyridinyl derivatives |
| 06/21/2001 | CA2392894A1 New p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 06/21/2001 | CA2316671A1 Nutritional products and method for treating and preventing cancer and other degenerative diseases |
| 06/20/2001 | EP1108429A2 An improved amino acid composition for providing an amino acid supplement or protein substitute, particularly for the treatment and/or management of certain diseases |
| 06/20/2001 | EP1108365A2 Encapsulated long chain alcohols |
| 06/20/2001 | EP1108364A2 Long chain alcohols admixed in sterol compounds |
| 06/20/2001 | EP1108068A1 T-type calcium channel |
| 06/20/2001 | EP1108051A2 Inducible expression system |
| 06/20/2001 | EP1108049A2 Adenoviruses deleted in the iva2, 100k and/or preterminal protein sequences |
| 06/20/2001 | EP1108039A2 Elongase genes and uses thereof |
| 06/20/2001 | EP1108019A2 Protein transport-associated molecules |
| 06/20/2001 | EP1107988A2 Method for chromatographically purifying insulins |
| 06/20/2001 | EP1107987A2 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor |
| 06/20/2001 | EP1107986A1 Protein domains in the hepatic glycogen-targeting subunit of protein phosphatase 1 and methods of making and using the same |
| 06/20/2001 | EP1107978A1 Secreted proteins and polynucleotides encoding them |
| 06/20/2001 | EP1107973A1 Novel compounds |
| 06/20/2001 | EP1107953A1 Hydroxamic acid derivatives as proteinase inhibitors |
| 06/20/2001 | EP1107940A1 Vitamin d3 mimics |
| 06/20/2001 | EP1107793A1 Dextran-leptin conjugates, pharmaceutical compositions and related methods |
| 06/20/2001 | EP1107778A1 Treatment of disease states |
| 06/20/2001 | EP1107758A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase |
| 06/20/2001 | EP1107746A2 Methods of using and compositions comprising dopamine reuptake inhibitors |
| 06/20/2001 | EP1107744A2 Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome |
| 06/20/2001 | EP1107741A1 Orally administered controlled drug delivery system providing temporal and spatial control |
| 06/20/2001 | EP1107738A1 Novel pharmaceutical salt form |
| 06/20/2001 | EP0889875B1 Cyclopropyl alkanoic acid derivatives |
| 06/20/2001 | EP0768308B1 derivatives of pyroglutaminic acid, preparation process and applications |
| 06/20/2001 | EP0757682B1 Benzofuran derivatives useful as inhibitors of bone resorption |
| 06/20/2001 | EP0579733B1 Thiazolidinedione derivatives, production and use thereof |
| 06/20/2001 | CN1300303A Enzyme inhibitors |
| 06/20/2001 | CN1300291A Modulators of protein tyrosine phosphatases |
| 06/20/2001 | CN1300285A Oxyiminoalkanoic acid derivatives |
| 06/20/2001 | CN1300282A Pyrazole derivatives as P-38 MAP kinase inhibitors |
| 06/20/2001 | CN1300277A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 06/20/2001 | CN1300212A Novel fatty analogues for the treatment of obesity, hypertension and fatty liver |
| 06/20/2001 | CN1300211A Novel fatty analogues for the treatment of premary and secondary restenosis |
| 06/20/2001 | CN1300187A Dietary supplement derived from fermented milks for the prevention of osteoporosis |
| 06/20/2001 | CN1299668A Multifunctional calcium tablet and its production process |
| 06/20/2001 | CN1299663A Diabetes treating medicine |
| 06/20/2001 | CN1299662A Diabetes treating medicine |
| 06/20/2001 | CN1299648A Hydrolytic nucleic acid solution |
| 06/20/2001 | CN1299602A Rhodiola tea |
| 06/20/2001 | CN1067260C Chinese drug for curing diabetes |
| 06/20/2001 | CN1067250C Neutral calcium-supplementary preparation |
| 06/19/2001 | US6248909 Triglyceride and composition comprising the same |
| 06/19/2001 | US6248897 From beta-methyl l-aspartate |
| 06/19/2001 | US6248791 Stimulating the differentiation of preadipocytic cells and therapies based thereon |
| 06/19/2001 | US6248787 Reducing cachexia |
| 06/19/2001 | US6248781 Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR) |
| 06/19/2001 | US6248753 Bicyclic compounds |
| 06/19/2001 | US6248749 Use of inhibitors of the activity of retinoic acid for treating sensit ive skin and/or acute damage induced by UV radiation |
| 06/19/2001 | US6248747 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines |
| 06/19/2001 | US6248717 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 06/19/2001 | US6248713 Cell adhesion inhibitors |
| 06/19/2001 | US6248594 Kinesin-like motor protein |
| 06/19/2001 | US6248527 Method of detecting risk of type II diabetes based on mutations found in carboxypeptidase E |
| 06/19/2001 | US6248390 Fiber-water—water containing soluble fiber |
| 06/19/2001 | US6248375 Food bar |
| 06/19/2001 | US6248363 Improved delivery of hydrophilic or hydrophobic pharmaceutical active ingredients, such as drugs, nutraceuticals, cosmeceuticals and diagnostic agents |
| 06/19/2001 | US6248347 Calcium assimilation accelerator and calcium-supplementing diet comprising and a method for accelerating calcium assimilation |
| 06/19/2001 | US6248326 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor |
| 06/19/2001 | US6248318 Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers |
| 06/19/2001 | CA2172187C Method of incorporating drugs into a polymer component of stents |
| 06/19/2001 | CA2013893C Tetrahydrobenz¬c,d|indole serotonin agonists |
| 06/19/2001 | CA1341260C Pharmaceutical and/or dietary compsitions containing l-carnitine and l- lysine |
| 06/14/2001 | WO2001042789A1 MARKERS FOR IDENTIFICATION AND ISOLATION OF PANCREATIC ISLET α AND β CELL PROGENITORS |
| 06/14/2001 | WO2001042499A1 Method of testing remedy or preventive for hyperlipemia |
| 06/14/2001 | WO2001042471A2 Polypeptides and polynucleotides encoding same |
| 06/14/2001 | WO2001042305A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001042301A1 Interferon-alpha induced gene |
| 06/14/2001 | WO2001042288A2 G-protein coupled receptors |
| 06/14/2001 | WO2001042265A2 N6 heterocyclic 8-modified adenosine derivatives |
| 06/14/2001 | WO2001042246A2 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS |
| 06/14/2001 | WO2001042244A1 Novel 1,8-naphthyridin-2(1h)-one derivatives |
| 06/14/2001 | WO2001042238A1 Heterocyclic derivatives |
| 06/14/2001 | WO2001042231A2 Polyhydroxystilbenes and stilbene oxides as antisoriatic agents and protein kinase inhibitors |
| 06/14/2001 | WO2001042222A1 Polymorphic crystalline forms of celecoxib |
| 06/14/2001 | WO2001042221A1 Solid-state form of celecoxib having enhanced bioavailability |
| 06/14/2001 | WO2001042217A1 Beta-3 adrenoceptor agonists |
| 06/14/2001 | WO2001042216A2 Caspase inhibitors and uses thereof |
| 06/14/2001 | WO2001042209A1 Process for the preparation of amorphous atorvastatin |
| 06/14/2001 | WO2001042193A1 β2-ADRENERGIC RECEPTOR AGONISTS |
| 06/14/2001 | WO2001042191A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy |
| 06/14/2001 | WO2001041812A2 Amphiphilic polymers and polypeptide conjugates comprising same |
| 06/14/2001 | WO2001041809A1 Application of polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of oncological diseases and the diabetes mellitus |
| 06/14/2001 | WO2001041792A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001041777A1 Calcium sorbefacients and process for producing the same |
| 06/14/2001 | WO2001041768A2 Use of hymenialdisine or derivatives thereof in the manufacture of medicaments |
| 06/14/2001 | WO2001041766A1 The combination of a serotonin reuptake inhibitor and irindalone |
| 06/14/2001 | WO2001041762A2 Valdecoxib compositions |
| 06/14/2001 | WO2001041761A2 Valdecoxib compositions |
| 06/14/2001 | WO2001041760A2 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |